Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
ABVX
ABVX News & Events
-
Add to Watchlist
Trade ABVX Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ABVX News
Abivax Under Investigation Following Phase 3 Trial Results, Shares Plummet
Jun 11 2026
PRnewswire
Abivax Under Investigation for Securities Violations Amid Trial Results
Jun 10 2026
Globenewswire
Abivax Under Investigation Following Phase 3 Trial Results, Shares Plummet
Jun 08 2026
PRnewswire
ABIVAX and Others See Significant Stock Gains
Jun 04 2026
NASDAQ.COM
Abivax's Drug Trial Data Triggers Stock Volatility
Jun 03 2026
Fool
Abivax's Drug Development Progress and Market Reaction
Jun 03 2026
NASDAQ.COM
Jefferies Downgrades Abivax Amid Cancer Concerns
Jun 03 2026
PRnewswire
Abivax Shares Plunge 44% Following Cancer Cases in Trial
Jun 03 2026
Newsfilter
Show More News
ABVX Events
06/03 12:10
Abivax Shares Rise 13.1% to $81.97
Abivax is up 13.1%, or $9.47 to $81.97.
06/03 10:10
Abivax Stock Rises 14.1% to $82.74
Abivax is up 14.1%, or $10.24 to $82.74.
Show More Events
ABVX Monitor News
Abivax Faces Investigation After Troubling Phase 3 Trial Results
Jun 17 2026
Abivax Faces Investigation After Negative Phase 3 Trial Results
Jun 15 2026
Abivax Faces Investigation Amid Negative Trial Results
Jun 10 2026
Jefferies Downgrades Abivax Amid Cancer Concerns
Jun 05 2026
Abivax Shares Plunge 44% Following Cancer Cases in Trial
Jun 04 2026
Abivax Shares Plunge 32% Following New Drug Data Release
Jun 02 2026
Abivax Reports Positive Clinical Trial Results for Obefazimod
May 27 2026
Abivax Reports Strong Q1 Results and Promising Obefazimod Data
May 26 2026
Show More Monitor News
ABVX Earnings Analysis
No Data
People Also Watch
